Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Cash from Discontinued Operations: 2018

Historic Cash from Discontinued Operations for Fortress Biotech (FBIO) over the last 1 years, with Dec 2018 value amounting to $5.7 million.

  • Fortress Biotech's Cash from Discontinued Operations was N/A to $5.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$1.8 million, marking a year-over-year change of. This contributed to the annual value of -$1.8 million for FY2018, which is 56.96% up from last year.
  • Per Fortress Biotech's latest filing, its Cash from Discontinued Operations stood at $5.7 million for Q4 2018, which was up 157.73% from $2.2 million recorded in Q3 2018.
  • Fortress Biotech's 5-year Cash from Discontinued Operations high stood at $5.7 million for Q4 2018, and its period low was -$7.4 million during Q2 2018.
  • Moreover, its 1-year median value for Cash from Discontinued Operations was -$77,500 (2018), whereas its average is -$446,250.